Insulet (NASDAQ: PODD) reported Q4 EPS of $1.44, $0.02 worse than the analyst estimate of $1.46. Revenue for the quarter came in at $783.8 million versus the consensus estimate of $768.59 million.

For earnings history and earnings-related data on Insulet (PODD) click here.